Centuple Global Limited (BOM:531099)
India · Delayed Price · Currency is INR 37.59
+3.33 (9.72%)
At close: Aug 4, 2026
Centuple Global Financials Overview
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 5,738 | 5,738 | 5.01 | 11.31 | 11.62 | 20.12 |
Revenue Growth | 114387.41% | 114387.41% | -55.68% | -2.66% | -42.26% | 314.82% |
Gross Profit Gross Profit Growth | 45.79 | 45.79 | 5.01 | 11.31 | 11.62 | 14.92 |
Operating Income Operating Income Growth | 22.82 | 22.82 | 0.48 | 0.23 | -0.81 | -0.22 |
Net Income Net Income Growth | 15.07 | 15.07 | 0.25 | 0.3 | -0.79 | -0.37 |
Earnings Per Share EPS Growth | 2.76 | 2.76 | 0.05 | 0.06 | -0.14 | -0.07 |
EPS Growth | 5841.62% | 5841.62% | -15.89% | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Tobacco Products Tobacco Products Growth | 763.25 | 763.25 | - | - | - | - |
Fmcg Products Fmcg Products Growth | 4,972 | 4,972 | - | - | - | - |
Unallocable Unallocable Growth | 2.5 | 2.5 | - | - | - | - |
Wholesale - Drugs Wholesale - Drugs Growth | - | - | 5.01 | 11.31 | 11.62 | 20.12 |
Total Total Growth | 5,738 | 5,738 | 5.01 | 11.31 | 11.62 | 20.12 |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 0.88 | 0.88 | 0.25 | 0.14 | 0.53 | 0.54 |
Total Debt Total Debt Growth | 67.35 | 67.35 | - | - | 1.47 | - |
Net Cash (Debt) Net Cash Growth | -66.47 | -66.47 | 0.25 | 0.14 | -0.94 | 0.54 |
Net Cash Growth | - | - | 82.48% | - | - | -90.33% |
Net Cash Per Share Net Cash Per Share Growth | -12.17 | -12.17 | 0.05 | 0.03 | -0.17 | 0.10 |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | -280.13 | -280.13 | 1.94 | -0.03 | 0.14 | -5 |
Capital Expenditures CapEx Growth | -0.2 | -0.2 | - | -0.14 | - | - |
Free Cash Flow Free Cash Flow Growth | -280.32 | -280.32 | 1.94 | -0.17 | 0.14 | -5 |
Free Cash Flow Growth | - | - | - | - | - | - |
| Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 0.80% | 0.80% | 100.00% | 100.00% | 100.00% | 74.16% |
Operating Margin | 0.40% | 0.40% | 9.54% | 2.00% | -6.94% | -1.10% |
Pretax Margin | 0.40% | 0.40% | 9.46% | 1.98% | -6.94% | -1.11% |
Profit Margin | 0.26% | 0.26% | 5.07% | 2.67% | -6.76% | -1.81% |
FCF Margin | -4.88% | -4.88% | 38.67% | -1.51% | 1.18% | -24.85% |
| Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 5, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 13.62 | 17.05 | 275.35 | 178.90 | - | - |
P/FCF Ratio | - | - | 36.09 | - | 188.10 | - |
PS Ratio | 0.04 | 0.05 | 13.95 | 4.78 | 2.22 | 0.80 |